[1]
|
American Cancer Society. Facts and Figures, 2017.
https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2017/cancer-facts-and-figures-2017.pdf
|
[2]
|
Agency for Healthcare Research and Quality (2017) Evidence Synthesis No.158: Screening for Cervical Cancer with High-Risk Human Papillomavirus Testing: A Systematic Evidence Review for the US Preventive Services Task Force.
https://www.uspreventiveservicestaskforce.org/Home/GetFileByID/3279
|
[3]
|
Curry, S.J., Krist, A.H., Owens, D.K., et al. (2018) Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement. JAMA: The Journal of the American Medical Association, 320, 674-686.
https://doi.org/10.1001/jama.2018.10897
|
[4]
|
Huh, W.K., Ault, K.A., Chelmow, D., et al. (2015) Use of Primary High-Risk Human Papillomavirus Testing for Cervical Cancer Screening: Interim Clinical Guidance. Obstetrics & Gynecology, 125, 330-337.
https://doi.org/10.1097/AOG.0000000000000669
|
[5]
|
(2016) Practice Bulletin No.168 Summary: Cervical Cancer Screening and Prevention. Obstetrics & Gynecology, 128, 923-925. https://doi.org/10.1097/AOG.0000000000001699
|
[6]
|
Saslow, D., Solomon, D., Lawson, H.W., et al. (2012) American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of cervical Cancer. CA: A Cancer Journal for Clinicians, 62, 147-172.
https://doi.org/10.3322/caac.21139
|
[7]
|
Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents (2019) Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents: Recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. https://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf
|
[8]
|
Massad, L.S., Einstein, M.H., Huh, W.K., et al. (2013) 2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors. Obstetrics & Gynecology, 121, 829-846.
https://doi.org/10.1097/AOG.0b013e3182883a34
|
[9]
|
Kuppermann, M. and Sawaya, G.F. (2015) Shared Deci-sion-Making: Easy to Evoke, Challenging to Implement. JAMA Internal Medicine, 175, 167-168. https://doi.org/10.1001/jamainternmed.2014.4606
|
[10]
|
Sawaya, G.F., Sansted, E., Alarid-Escudero, F., et al. (2019) Estimated Quality of Life and Economic Outcomes Associated with 12 Cervical Cancer Screening Strategies: A Cost-Effectiveness Analysis. JAMA Internal Medicine, 179, 867-878.
|